Summit Therapeutics Goodwill

Summit Therapeutics's goodwill stands at $2M as of June 2026. That compares with $2M in the prior-year period — down 3.5% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Summit Therapeutics reported $2M in goodwill versus $2M a year earlier — a 3.5% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $2M in the prior-year period — down 3.5% year over year. Sustained growth in goodwill can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Summit Therapeutics's goodwill evolved across reporting periods, while the comparison chart places SMMT next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.